A citation-based method for searching scientific literature

Meysam Amidfar, Gislaine Zilli Réus, Airam Barbosa de Moura, João Quevedo, Yong-Ku Kim. Adv Exp Med Biol 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Treatment of depression with ketamine does not change plasma levels of brain-derived neurotrophic factor or vascular endothelial growth factor.
Gustavo C Medeiros, Dede Greenstein, Bashkim Kadriu, Peixiong Yuan, Lawrence T Park, Todd D Gould, Carlos A Zarate. J Affect Disord 2021
5
100

BDNF/NF-κB Signaling in the Neurobiology of Depression.
Ariel Caviedes, Carlos Lafourcade, Claudio Soto, Ursula Wyneken. Curr Pharm Des 2017
73
100

Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression.
Marion J F Levy, Fabien Boulle, Harry W Steinbusch, Daniël L A van den Hove, Gunter Kenis, Laurence Lanfumey. Psychopharmacology (Berl) 2018
68
100

Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization.
Joshua Greene, Mounira Banasr, Boyoung Lee, Jennifer Warner-Schmidt, Ronald S Duman. Neuropsychopharmacology 2009
117
100

Anhedonia predicts suicidal ideation in a large psychiatric inpatient sample.
E Samuel Winer, Michael R Nadorff, Thomas E Ellis, Jon G Allen, Steve Herrera, Taban Salem. Psychiatry Res 2014
65
100

Vascular endothelial growth factor and pigment epithelial-derived factor in the peripheral response to ketamine.
Claire L McGrory, Karen M Ryan, Bronagh Gallagher, Declan M McLoughlin. J Affect Disord 2020
3
100

Association between plasma levels of BDNF and the antisuicidal effects of repeated ketamine infusions in depression with suicidal ideation.
Wei Zheng, Yan-Ling Zhou, Cheng-Yu Wang, Xiao-Feng Lan, Bin Zhang, Su-Miao Zhou, Su Yan, Ming-Zhe Yang, Sha Nie, Yu-Ping Ning. Ther Adv Psychopharmacol 2020
1
100

Neural representation of reward in recovered depressed patients.
Ciara McCabe, Philip J Cowen, Catherine J Harmer. Psychopharmacology (Berl) 2009
174
100

Anhedonia and general distress show dissociable ventromedial prefrontal cortex connectivity in major depressive disorder.
C B Young, T Chen, R Nusslock, J Keller, A F Schatzberg, V Menon. Transl Psychiatry 2016
41
100

VEGF as a potential target for therapeutic intervention in depression.
Jennifer L Warner-Schmidt, Ronald S Duman. Curr Opin Pharmacol 2008
109
100

Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive Disorder.
Roger S McIntyre, Henrik Loft, Michael Cronquist Christensen. Neuropsychiatr Dis Treat 2021
3
100

Monitoring ketamine treatment response in a depressed patient via peripheral mammalian target of rapamycin activation.
Magdalena C Denk, Christiane Rewerts, Florian Holsboer, Angelika Erhardt-Lehmann, Christoph W Turck. Am J Psychiatry 2011
49
100

The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis.
Samuel T Wilkinson, Elizabeth D Ballard, Michael H Bloch, Sanjay J Mathew, James W Murrough, Adriana Feder, Peter Sos, Gang Wang, Carlos A Zarate, Gerard Sanacora. Am J Psychiatry 2018
236
100

Changes in symptoms of anhedonia in adults with major depressive or bipolar disorder receiving IV ketamine: Results from the Canadian Rapid Treatment Center of Excellence.
Nelson B Rodrigues, Roger S McIntyre, Orly Lipsitz, Danielle S Cha, Yena Lee, Hartej Gill, Amna Majeed, Lee Phan, Flora Nasri, Roger Ho,[...]. J Affect Disord 2020
4
100

The role of neurotrophins in bipolar disorder.
Gustavo Scola, Ana Cristina Andreazza. Prog Neuropsychopharmacol Biol Psychiatry 2015
35
100

Therapeutic Potentials of Ketamine and Esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature.
Giovanni Martinotti, Stefania Chiappini, Mauro Pettorruso, Alessio Mosca, Andrea Miuli, Francesco Di Carlo, Giacomo D'Andrea, Roberta Collevecchio, Ilenia Di Muzio, Stefano L Sensi,[...]. Brain Sci 2021
4
100

Role of Neuronal VEGF Signaling in the Prefrontal Cortex in the Rapid Antidepressant Effects of Ketamine.
Satoshi Deyama, Eunyoung Bang, Eric S Wohleb, Xiao-Yuan Li, Taro Kato, Danielle M Gerhard, Sophie Dutheil, Jason M Dwyer, Seth R Taylor, Marina R Picciotto,[...]. Am J Psychiatry 2019
33
100

Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.
Shih-Jen Tsai, Chen-Jee Hong, Ying-Jay Liou, Tai-Jui Chen, Mao-Liang Chen, Sheue-Jane Hou, Feng-Chang Yen, Younger W-Y Yu. Psychiatry Res 2009
23
100

Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review.
Bing Cao, Judy Zhu, Hannah Zuckerman, Joshua D Rosenblat, Elisa Brietzke, Zihang Pan, Mehala Subramanieapillai, Caroline Park, Yena Lee, Roger S McIntyre. Prog Neuropsychopharmacol Biol Psychiatry 2019
33
100

The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder.
Bing Cao, Caroline Park, Mehala Subramaniapillai, Yena Lee, Michelle Iacobucci, Rodrigo B Mansur, Hannah Zuckerman, Lee Phan, Roger S McIntyre. Front Psychiatry 2019
15
100

VEGF regulates antidepressant effects of lamotrigine.
Rongju Sun, Nanxin Li, Tanshi Li. Eur Neuropsychopharmacol 2012
17
100


VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants.
Jennifer L Warner-Schmidt, Ronald S Duman. Proc Natl Acad Sci U S A 2007
324
100

Neural correlates of change in major depressive disorder anhedonia following open-label ketamine.
Níall Lally, Allison C Nugent, David A Luckenbaugh, Mark J Niciu, Jonathan P Roiser, Carlos A Zarate. J Psychopharmacol 2015
99
100

Comparative effectiveness of esketamine in the treatment of anhedonia in bipolar and unipolar depression.
Rodrigo Simonini Delfino, José Alberto Del-Porto, Juliana Surjan, Eduardo Magalhães, Lorena Catarina Del Sant, Ana Cecílica Lucchese, Marco Aurélio Tuena, Carolina Nakahira, Victor Augusto Rodoalho Fava, Matheus Souza Steglich,[...]. J Affect Disord 2021
5
100

A rating scale for depression.
M HAMILTON. J Neurol Neurosurg Psychiatry 1960
100

Dimensions in major depressive disorder and their relevance for treatment outcome.
Elske Vrieze, Koen Demyttenaere, Ronny Bruffaerts, Dirk Hermans, Diego A Pizzagalli, Pascal Sienaert, Titia Hompes, Peter de Boer, Mark Schmidt, Stephan Claes. J Affect Disord 2014
60
100

Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials.
Elizabeth D Ballard, Kathleen Wills, Níall Lally, Erica M Richards, David A Luckenbaugh, Tessa Walls, Rezvan Ameli, Mark J Niciu, Nancy E Brutsche, Lawrence Park,[...]. J Affect Disord 2017
40
100

Ketamine-induced changes in plasma brain-derived neurotrophic factor (BDNF) levels are associated with the resting-state functional connectivity of the prefrontal cortex.
Marie Woelfer, Meng Li, Lejla Colic, Thomas Liebe, Xin Di, Bharat Biswal, James Murrough, Volkmar Lessmann, Tanja Brigadski, Martin Walter. World J Biol Psychiatry 2020
16
100

Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials.
Katrina Witt, Jennifer Potts, Anna Hubers, Michael F Grunebaum, James W Murrough, Colleen Loo, Andrea Cipriani, Keith Hawton. Aust N Z J Psychiatry 2020
37
100


Association of plasma VEGF levels and the antidepressant effects of ketamine in patients with depression.
Wei Zheng, Yan-Ling Zhou, Cheng-Yu Wang, Xiao-Feng Lan, Bin Zhang, Su-Miao Zhou, Su Yan, Ming-Zhe Yang, Sha Nie, Yu-Ping Ning. Ther Adv Psychopharmacol 2021
2
100

Neurotrophic and Antidepressant Actions of Brain-Derived Neurotrophic Factor Require Vascular Endothelial Growth Factor.
Satoshi Deyama, Eunyoung Bang, Taro Kato, Xiao-Yuan Li, Ronald S Duman. Biol Psychiatry 2019
36
100

Copper and anti-anhedonic effect of ketamine in treatment-resistant depression.
Jakub Słupski, Wiesław Jerzy Cubała, Natalia Górska, Anita Słupska, Maria Gałuszko-Węgielnik. Med Hypotheses 2020
7
100

Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression.
N Lally, A C Nugent, D A Luckenbaugh, R Ameli, J P Roiser, C A Zarate. Transl Psychiatry 2014
132
100

Neurocognitive performance and repeated-dose intravenous ketamine in major depressive disorder.
Wei Zheng, Yan-Ling Zhou, Wei-Jian Liu, Cheng-Yu Wang, Yan-Ni Zhan, Han-Qiu Li, Li-Jian Chen, Ming-D Li, Yu-Ping Ning. J Affect Disord 2019
28
100

Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression.
Wei Zheng, Yan-Ling Zhou, Wei-Jian Liu, Cheng-Yu Wang, Yan-Ni Zhan, Han-Qiu Li, Li-Jian Chen, Ming Ding Li, Yu-Ping Ning. J Psychiatr Res 2018
51
100

Chronic ketamine use increases serum levels of brain-derived neurotrophic factor.
Valerio Ricci, Giovanni Martinotti, Francesca Gelfo, Federico Tonioni, Carlo Caltagirone, Pietro Bria, Francesco Angelucci. Psychopharmacology (Berl) 2011
42
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.